The Partnership to Improve Patient Care (PIPC) has released a public opinion poll by Morning Consult regarding the use of cost-effectiveness assessments to determine value of coverage and treatment costs. The survey demonstrates that voters resoundingly reject the main tenets of cost-effectiveness analyses with 82 percent of American voters objecting to their use in determining health care coverage and reimbursement decisions. These types of measures, which are often used outside of the U.S. to limit patient access to medicines, have been frequently criticized as discriminatory by patients and persons with disabilities. Increasingly, policymakers and payers have proposed to use these same tools to limit coverage for Medicare and Medicaid beneficiaries.
Click here to view a blog post on the poll by PIPC Chairman Tony Coelho.
Click here to view a blog post on the poll by PIPC Chairman Tony Coelho.
Additional key findings include:
The survey addresses recent proposals calling for government-determined value determinations based on cost-effectiveness analyses. These analyses would rely on quality of adjusted life (QALY) standards as a metric that determine the value of a treatment by assigning a number to patients based on their condition or disease.
PIPC Chairman Tony Coelho stated, “This survey highlights the importance of PIPC’s long-standing efforts to support patient-centered approaches over cost-effectiveness assessments that determine the value of patient care in a one-size-fits-all approach. Patients should have the freedom to decide with their doctor, not the government, over which treatment or care is best suited for their situation and needs. PIPC has worked too long and too hard to support patients and provide them with a meaningful voice in determining their health care decisions.”
- Just over 2,000 registered voters polled, a little over 90 percent believe healthcare decisions should be made between patients and their doctors without government interference.
- Almost 75 percent of polled voters concerned with the idea of the government or their health insurance company using cost-effectiveness standards to set policy.
- 7 in 10 voters believe it is important for Congress to continue funding Patient Centered Outcomes Research Initiative (PCORI) and support PCORI conducting research on the comparative health value of different drugs.
- 85 percent of voters believe it is important to have the safeguard in Medicare that prevents the government from using cost-effectiveness to make coverage or payment decisions, and more than two-thirds support expanding these protections to other health care programs.
The survey addresses recent proposals calling for government-determined value determinations based on cost-effectiveness analyses. These analyses would rely on quality of adjusted life (QALY) standards as a metric that determine the value of a treatment by assigning a number to patients based on their condition or disease.
PIPC Chairman Tony Coelho stated, “This survey highlights the importance of PIPC’s long-standing efforts to support patient-centered approaches over cost-effectiveness assessments that determine the value of patient care in a one-size-fits-all approach. Patients should have the freedom to decide with their doctor, not the government, over which treatment or care is best suited for their situation and needs. PIPC has worked too long and too hard to support patients and provide them with a meaningful voice in determining their health care decisions.”
| Poll: Americans Support Patient-Centered Solutions |
